---
figid: PMC1346955__zjv0030673320011
figlink: /pmc/articles/PMC1346955/figure/f11/
number: F11
caption: Model for the interaction between activated MEK and the suppression of PKR
  function during viral infection of tumor cells by Δγ134.5 mutant viruses. Earlier
  studies demonstrated that activation of the ERK kinase (MEK)/ERK pathway by either
  oncogenic activating mutations of RAS isoforms, point mutations within B-RAF alleles,
  or receptor tyrosine kinase activation/overexpression is involved in transformation
  and tumor progression. In addition, Ras-independent activation of Raf/MEK/ERK signaling
  is cell and tumor type specific. This report shows that activated MEK suppresses
  PKR autophosphorylation and effectively blocks PKR-mediated eIF-2α phosphorylation.
  Tumor cells with activated MEK/ERK signaling therefore are exquisitely permissive
  to Δγ134.5 mutant viral replication and oncolysis.
pmcid: PMC1346955
papertitle: Activated MEK Suppresses Activation of PKR and Enables Efficient Replication
  and In Vivo Oncolysis by Δγ134.5 Mutants of Herpes Simplex Virus 1.
reftext: Kerrington D. Smith, et al. J Virol. 2006 Feb;80(3):1110-1120.
pmc_ranked_result_index: '100348'
pathway_score: 0.9539138
filename: zjv0030673320011.jpg
figtitle: The interaction between activated MEK and the suppression of PKR function
  during viral infection of tumor cells by ΔG134.5 mutant viruses
year: '2006'
organisms: Homo sapiens
ndex: 39c588e8-dee7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC1346955__zjv0030673320011.html
  '@type': Dataset
  description: Model for the interaction between activated MEK and the suppression
    of PKR function during viral infection of tumor cells by Δγ134.5 mutant viruses.
    Earlier studies demonstrated that activation of the ERK kinase (MEK)/ERK pathway
    by either oncogenic activating mutations of RAS isoforms, point mutations within
    B-RAF alleles, or receptor tyrosine kinase activation/overexpression is involved
    in transformation and tumor progression. In addition, Ras-independent activation
    of Raf/MEK/ERK signaling is cell and tumor type specific. This report shows that
    activated MEK suppresses PKR autophosphorylation and effectively blocks PKR-mediated
    eIF-2α phosphorylation. Tumor cells with activated MEK/ERK signaling therefore
    are exquisitely permissive to Δγ134.5 mutant viral replication and oncolysis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SOS1
  - PRKCI
  - MAPK3
  - NRAS
  - MAP2K1
  - PRKCQ
  - PRKCH
  - KRAS
  - HRAS
  - BRAF
  - PRKCG
  - PRKCE
  - RAF1
  - SOS2
  - PIK3CA
  - ARAF
  - PIK3R5
  - PRKCA
  - PRKCD
  - RAC1
  - MAP2K2
  - RAC2
  - PIK3R6
  - PRKCB
  - RAC3
  - PAK6
  - RHOG
  - PAK5
  - PAK2
  - PRKCZ
  - PAK4
  - PAK1
  - PIK3CD
  - PAK3
  - PRKD3
  - EIF2AK2
  - PIK3R4
  - PIK3CG
  - PIK3CB
  - PIK3R3
  - GRB2
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: ERK1/2)
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: B-Raf
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK6
  entrez: '56924'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK5
  entrez: '57144'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK2
  entrez: '5062'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK4
  entrez: '10298'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK1
  entrez: '5058'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK3
  entrez: '5063'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKR
  symbol: PKR
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK2
  entrez: '5610'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: GRB2.
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC1346955__F11
redirect_from: /figures/PMC1346955__F11
figtype: Figure
---
